US investigating Abbott stent sale

Image
Bloomberg New York
Last Updated : Jan 29 2013 | 1:33 AM IST

Abbott Laboratories said it received a subpoena last month from the US Justice Department in connection with its sales and marketing of bile-duct stents.

The government is investigating whether the company violated civil or criminal laws in connection with Medicare and Medicaid reimbursements paid to third parties, Abbott of Abbott Park, Illinois, said today in a filing with the US Securities and Exchange Commission.

The company said it doesn’t anticipate a “material adverse effect” on company finances.

The US Food and Drug Administration warned about illegal sales of stents when it met in March 2007 with the companies that make the devices, among them Boston Scientific Corp, Alveolus Inc and Johnson & Johnson.

Boston Scientific, based in Natick, Massachusetts said in February the Justice Department was investigating whether the company and other suppliers were illegally promoting the devices for unapproved uses.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 28 2008 | 12:00 AM IST

Next Story